Growth Metrics

Merck (MRK) Leases (2019 - 2025)

Merck (MRK) has disclosed Leases for 7 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Leases rose 10.0% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 10.0% year-over-year, with the annual reading at $1.5 billion for FY2025, 10.0% up from the prior year.
  • Leases for Q4 2025 was $1.5 billion at Merck, up from $1.4 billion in the prior quarter.
  • The five-year high for Leases was $1.6 billion in Q4 2021, with the low at $1.3 billion in Q4 2022.
  • Average Leases over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
  • The sharpest move saw Leases decreased 15.13% in 2022, then rose 10.0% in 2025.
  • Over 5 years, Leases stood at $1.6 billion in 2021, then fell by 15.13% to $1.3 billion in 2022, then increased by 6.76% to $1.4 billion in 2023, then dropped by 4.66% to $1.4 billion in 2024, then grew by 10.0% to $1.5 billion in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $1.5 billion, $1.4 billion, and $1.4 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.